Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/53596
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Androgens and polycystic ovary syndrome |
Author: | Nisenblat, V. Norman, R. |
Citation: | Current Opinion in Endocrinology, Diabetes and Obesity, 2009; 16(3):224-231 |
Publisher: | Lippincott Williams & Wilkins, Ltd. |
Issue Date: | 2009 |
ISSN: | 1752-2978 1752-2978 |
Statement of Responsibility: | Vicki Nisenblat, Robert J. Norman |
Abstract: | <h4>Purpose of review</h4>Polycystic ovary syndrome (PCOS) is a common complex endocrine genetic disorder, which involves overproduction of androgens, leading to heterogeneous range of symptoms and associated with increased metabolic and cardiovascular morbidity. This review focuses on androgen biosynthesis, use, metabolism in PCOS and clinical consequences of hyperandrogenism.<h4>Recent findings</h4>Controversial definition of the disorder and different phenotypic subgroups present a challenge for clinical and basic research. Further investigation of different phenotypes highlights the fact that PCOS probably represents a group of disorders with different etiologies. Prenatal androgen exposure and adolescent studies suggest early in life androgen excess as initiating factor of PCOS, but insufficient evidence available to confirm this hypothesis. Various intracellular signaling pathways implicated in PCOS steroidogenesis and in androgen action have been studied, however, PCOS pathogenesis remains obscure. Growing evidence links androgens with pathophysiology of PCOS and metabolic derangements.<h4>Summary</h4>Despite intensive investigation, etiology and underlying mechanisms of PCOS remain unclear, warranting further investigation. Better understanding of molecular and genetic basis might lead to invention of novel therapeutic approaches. Long-term interventional studies that lower androgen levels in women with hyperandrogenism might protect against metabolic and cardiovascular comorbidities are needed. |
Keywords: | androgens and polycystic ovary syndrome androgens and the ovary antiandrogens and polycystic ovary syndrome measurement of androgens in women |
DOI: | 10.1097/MED.0b013e32832afd4d |
Published version: | http://dx.doi.org/10.1097/med.0b013e32832afd4d |
Appears in Collections: | Aurora harvest Obstetrics and Gynaecology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.